Park Sung Sil, Kim Byung Chang, Lee Dong-Eun, Chang Hee Jin, Han Kyung Su, Kim Bun, Hong Chang Won, Sohn Dae Kyung, Lee Dong Woon, You Kiho, Park Sung Chan, Oh Jae Hwan
Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, South Korea.
Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, South Korea.
Gastrointest Endosc. 2025 Jun;101(6):1222-1232.e5. doi: 10.1016/j.gie.2024.11.036. Epub 2024 Nov 26.
The treatment of rectal neuroendocrine tumors (NETs) is determined by the risk of lymph node (LN) metastasis. The aim of this study was to stratify the risk of LN metastasis according to the number of risk factors and evaluate the long-term outcomes of patients initially treated endoscopically for rectal NETs.
We retrospectively analyzed 441 patients initially treated with endoscopy for rectal NETs; those who had at least 1 of the risk factors for LN metastasis were defined as high-risk patients. LN metastasis rates were stratified according to the number of risk factors. Five-year overall survival and recurrence-free survival were compared between the high- and low-risk groups.
Pathologic size (odds ratio [OR], 1.208; 95% confidence interval [CI], 1.062-1.374; P = .001), resection margin invasion (+) (OR, 2.897; 95% CI, 1.057-7.936; P = .039), and angiolymphatic invasion (OR, 22.155; 95% CI, 7.563-64.904; P = .001) were risk factors for LN metastasis. The rate of LN metastasis increased as the number of risk factors increased (P = .001). The 5-year recurrence-free survival rates were 98.7% and 99% in the high- and low-risk groups, respectively, with no significant difference (P = .966). The 5-year overall survival rates were 100% and 99.5% in the high- and low-risk groups, with no significant difference (P = .571).
The risk of LN metastasis increased significantly when the number of risk factors increased in patients with rectal NETs. Patients who initially underwent endoscopic resection for rectal NETs exhibited a favorable long-term oncologic outcome if salvage treatments were performed, depending on the stratification of their risk factors.
直肠神经内分泌肿瘤(NETs)的治疗取决于淋巴结(LN)转移风险。本研究的目的是根据风险因素数量对LN转移风险进行分层,并评估最初接受内镜治疗的直肠NETs患者的长期预后。
我们回顾性分析了441例最初接受内镜治疗的直肠NETs患者;将具有至少1个LN转移风险因素的患者定义为高危患者。根据风险因素数量对LN转移率进行分层。比较高危组和低危组的5年总生存率和无复发生存率。
病理大小(优势比[OR],1.208;95%置信区间[CI],1.062 - 1.374;P = .001)、切缘浸润(+)(OR,2.897;95% CI,1.057 - 7.936;P = .039)和血管淋巴管浸润(OR,22.155;95% CI,7.563 - 64.904;P = .001)是LN转移的风险因素。LN转移率随风险因素数量增加而升高(P = .001)。高危组和低危组的5年无复发生存率分别为98.7%和99%,无显著差异(P = .966)。高危组和低危组的5年总生存率分别为100%和99.5%,无显著差异(P = .571)。
直肠NETs患者中,风险因素数量增加时,LN转移风险显著升高。最初接受内镜切除的直肠NETs患者,根据其风险因素分层进行挽救性治疗,可获得良好的长期肿瘤学预后。